What is the purpose of the Framingham Heart Study?
The purpose of the Framingham Heart Study is to provide a general cardiovascular risk profile for use in primary care. This study was first published in the Circulation journal in 2008 and provides an algorithm for assessing global cardiovascular risk in women (the Reynolds Risk Score) as well as guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults, as published by the Canadian Cardiovascular Society in 2016. Additionally, the US Department of Veterans Affairs and US Department of Defense have published a clinical practice guideline for the management of dyslipidemia for cardiovas- cular disease risk reduction in 2014, and the US Preventive Services Task Force has published recommendations for the use of aspirin and statins for primary prevention of cardiovascular disease and colorectal cancer. Finally, a systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease was conducted in 2014.